Blue Water Biotech, Inc. Banner Image

Blue Water Biotech, Inc.

  • Ticker BWV
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Blue Water Biotech, Inc. Logo Image
  • 11-50 Employees
  • Based in Cincinnati, Ohio
Blue Water Biotech Inc. (Nasdaq: BWV) is a biopharmaceutical company focused on developing transformational therapies to address significant health challenges globally. The company holds the rights to proprietary technology developed at the University of Oxford, Cincinnati Children's Hospital Medical Center (CCHMC), and St. Jude Children's Hospital. The company is developing a universalMore flu vaccine that will provide protection from all virulent strains in addition to licensing a novel norovirus (NoV) S&P nanoparticle versatile virus-like particle (VLP) vaccine platform from CCHMC to develop vaccines for multiple infectious diseases, including norovirus/rotavirus and malaria, among others. Additionally, Blue Water Vaccines is developing a Streptococcus pneumoniae (pneumococcus) vaccine candidate, designed to specifically prevent the highly infectious middle ear infections, known as Acute Otitis Media (AOM), in children.
Blue Water Biotech, Inc.

Most Recent Annual Report

Blue Water Biotech, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Blue Water Biotech, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!